Type 2 diabetes develops when your body stops responding properly to insulin and, over time, can no longer produce enough of it to keep blood sugar in a normal range. Unlike type 1 diabetes, which is an autoimmune condition, type 2 results from a combination of genetic predisposition, metabolic changes, lifestyle factors, and environmental exposures that build on each other over years or even decades.
Insulin Resistance: Where It Starts
The earliest driver of type 2 diabetes is insulin resistance. Insulin is a hormone that helps sugar move from your bloodstream into your cells for energy. When cells in your muscles, liver, and fat tissue stop responding to insulin efficiently, your pancreas compensates by producing more of it. For a while, this extra insulin keeps blood sugar levels normal. But the underlying problem is already in motion.
Insulin resistance doesn’t happen overnight. It often develops over years, fueled by excess body fat (especially around the abdomen), physical inactivity, and chronic low-grade inflammation. Many people with insulin resistance have no symptoms at all and wouldn’t know anything was wrong without a blood test. This “silent” phase is why type 2 diabetes often goes undiagnosed until complications appear.
How Visceral Fat Drives Inflammation
Not all body fat contributes equally to diabetes risk. Visceral fat, the fat stored deep in your abdomen around your organs, is far more metabolically active than the fat just beneath your skin. It acts almost like a separate organ, releasing inflammatory signaling molecules that interfere with how your body uses insulin.
When visceral fat expands, it releases excess fatty acids into the bloodstream, which triggers fat cells to pump out inflammatory compounds. One of these signals directly blocks insulin from connecting with its receptor on cells, essentially locking the door that insulin is trying to open. Another compound, produced at two to three times higher levels by abdominal fat compared to fat elsewhere in the body, travels straight to the liver through the portal vein and promotes insulin resistance there. The liver responds by producing inflammatory markers that circulate throughout the body.
As fat tissue grows, it also sends out chemical signals that recruit immune cells called macrophages. These macrophages infiltrate the fat tissue and release even more inflammatory molecules, creating a self-reinforcing cycle. The result is a state of chronic, low-level inflammation that progressively worsens insulin resistance in the liver, muscles, and fat tissue itself. This is why waist circumference is often a better predictor of diabetes risk than overall body weight.
Beta Cell Exhaustion Over Time
Your pancreas contains clusters of insulin-producing cells called beta cells. In the early stages of insulin resistance, these cells ramp up production to meet the increased demand. But they can’t sustain that pace indefinitely.
Research published in Frontiers in Endocrinology mapped beta cell function across the course of type 2 diabetes and found three distinct phases. In the first phase, lasting about four years after diagnosis, beta cell function actually improves slightly, likely because treatment reduces the toxic effects of high blood sugar and high fat levels. Then comes a steep decline lasting roughly 17 years, during which beta cell function drops by about 3% per year. Finally, function plateaus at a persistently low level, often too low for oral medications to work effectively.
The decline happens through several mechanisms. Prolonged exposure to high blood sugar and fatty acids is directly toxic to beta cells, causing them to die faster than they can be replaced. Some beta cells become “exhausted” and simply stop producing insulin. Others undergo a process where they lose their identity as insulin-producing cells and transform into different cell types entirely. Notably, people diagnosed at younger ages experience a faster rate of beta cell decline, which may explain why early-onset type 2 diabetes tends to be more aggressive.
Genetic Risk Factors
Your genes play a substantial role in determining whether you’ll develop type 2 diabetes. If one parent has the condition, your lifetime risk roughly doubles. If both parents have it, the risk climbs higher still. Studies of identical twins show that when one twin develops type 2 diabetes, the other has a 70% or greater chance of developing it too, far higher than in non-identical twins.
Researchers have identified well over 100 genetic regions linked to type 2 diabetes risk. One of the strongest associations involves a gene called TCF7L2, which affects how the body processes sugar and how well beta cells function. Other gene variants influence how your body stores fat, responds to insulin, or regulates appetite. Each individual variant contributes only a small increase in risk, but when many are present together, the cumulative effect is significant.
Genetics also helps explain the stark differences in diabetes rates across racial and ethnic groups. CDC data from 2021 to 2023 shows that 15.7% of American Indian or Alaska Native adults have diagnosed diabetes, compared to 12.2% of Black adults, 11.8% of Hispanic adults, 9.7% of Asian adults, and 7.1% of white adults. These disparities reflect a complex mix of genetic susceptibility, socioeconomic factors, access to healthcare, and differences in how and where the body stores fat.
Lifestyle and Diet
Physical inactivity is one of the most consistent risk factors for type 2 diabetes. When you exercise, your muscles pull sugar from the bloodstream even without much insulin. Regular movement also reduces visceral fat and lowers inflammation. Sedentary behavior does the opposite: it allows insulin resistance to build unchecked.
Diet matters in ways that go beyond total calories. Diets high in refined carbohydrates and added sugars cause frequent, large spikes in blood sugar that force the pancreas to work harder. Over time, this contributes to both insulin resistance and beta cell fatigue. Processed meats and sugary drinks are among the foods most consistently linked to higher diabetes risk in large population studies. On the other hand, diets rich in whole grains, vegetables, legumes, and healthy fats are associated with lower risk, partly because they produce slower, more gradual rises in blood sugar and partly because they reduce inflammation.
Sleep also plays a measurable role. Consistently getting fewer than six hours of sleep per night increases insulin resistance, raises appetite-stimulating hormones, and promotes weight gain. Shift workers, who experience chronic disruption of their body’s internal clock, have notably higher rates of type 2 diabetes.
Environmental Chemical Exposures
A growing body of evidence links certain synthetic chemicals to metabolic disruption and diabetes risk. These compounds, broadly called endocrine-disrupting chemicals, interfere with normal hormone signaling. Over 1,000 are recognized, and many are nearly impossible to avoid in modern life.
Bisphenol A (BPA), found in plastic water bottles, food containers, and the lining of metal cans, is one of the most studied. Roughly 93% of Americans have measurable levels of BPA in their urine. Although the body breaks it down quickly (its half-life is only four to five hours), constant low-level exposure from food packaging means most people are never truly free of it. Phthalates, used to soften plastics, appear in everything from food packaging to children’s toys to medical devices and have been linked to metabolic dysfunction in animal studies.
These chemicals behave differently from most toxins. They often have stronger effects at very low doses than at higher ones, following a U-shaped response curve that makes them difficult to study using traditional dose-response models. Their effects on insulin signaling and fat storage, while modest individually, may compound over a lifetime of exposure, particularly when combined with genetic susceptibility and other risk factors.
Age, Sex, and Other Risk Factors
Risk increases steadily with age, particularly after 45, as insulin sensitivity naturally declines and beta cell function gradually erodes. Muscle mass also tends to decrease with age, reducing one of the body’s most important sinks for blood sugar.
Women who develop gestational diabetes during pregnancy have a significantly elevated risk of developing type 2 diabetes later in life. Polycystic ovary syndrome (PCOS), a hormonal condition affecting roughly 1 in 10 women of reproductive age, is also strongly associated with insulin resistance and subsequent diabetes.
Other conditions that raise risk include high blood pressure, abnormal cholesterol levels (particularly high triglycerides and low HDL cholesterol), and a history of cardiovascular disease. These conditions share overlapping metabolic roots with type 2 diabetes and frequently occur together, a cluster sometimes called metabolic syndrome. Having metabolic syndrome doesn’t guarantee you’ll develop diabetes, but it signals that the underlying processes driving the disease are already active.